Pharmaceutical composition comprising a combination of an antidepressant and anxiolytic agent for the control of Depressive Disorders

摘要

Synergistic combination of an antidepressant and Selective inhibitor of the reuptake of 5-ht, as is the active Principle: sertraline and anxiolytic Agent belonging to the group of triazolobenzodiazepinas, as is the active Principle: alprazolam, which are formulated In a Single Dose to be administered orally in the form of capsules or tablets.It is indicated for the treatment and Control of diseases such as: Depressive Disorders and related diseases.